BioRestorative Therapies, Inc. (BRTX)
0.1991
-0.01
(-3.35%)
USD |
NASDAQ |
Aug 28, 16:00
0.2007
0.00 (0.00%)
After-Hours: 20:00
BioRestorative Therapies Total Long Term Debt (Quarterly) : 0.00 for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.0424M |
| June 30, 2023 | 0.0836M |
| March 31, 2023 | 0.1235M |
| December 31, 2022 | 0.1623M |
| September 30, 2022 | 0.1987M |
| June 30, 2022 | 0.2341M |
| March 31, 2022 | 0.2684M |
| December 31, 2021 | 0.4927M |
| September 30, 2021 | 6.181M |
| June 30, 2021 | 5.367M |
| March 31, 2021 | 5.104M |
| December 31, 2020 | 4.634M |
| September 30, 2020 | 0.4471M |
| June 30, 2020 | 0.4728M |
| March 31, 2020 | 8.519M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.668M |
| September 30, 2019 | 7.683M |
| June 30, 2019 | 5.700M |
| March 31, 2019 | 4.001M |
| December 31, 2018 | 4.150M |
| September 30, 2018 | 4.342M |
| June 30, 2018 | 4.834M |
| March 31, 2018 | 3.778M |
| December 31, 2017 | 3.662M |
| September 30, 2017 | 2.935M |
| June 30, 2017 | 2.553M |
| March 31, 2017 | 2.078M |
| December 31, 2016 | 2.157M |
| September 30, 2016 | 1.785M |
| June 30, 2016 | 1.820M |
| March 31, 2016 | 1.317M |
| December 31, 2015 | 1.312M |
| September 30, 2015 | 1.666M |
| June 30, 2015 | 1.145M |
| March 31, 2015 | 5.771M |
| December 31, 2014 | 5.738M |
| September 30, 2014 | 5.794M |
| June 30, 2014 | 5.982M |
| March 31, 2014 | 5.465M |
| December 31, 2013 | 5.514M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 203.20M |
| CareDx, Inc. | 13.20M |
| Natera, Inc. | 143.07M |
| Exagen, Inc. | 26.68M |
| Sera Prognostics, Inc. | 3.001M |